| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 |
 910 19 |
| Ultima descărcare din IBN: 2023-11-20 21:16 |
 SM ISO690:2012DIACONU, Georgeta, GRIGORE, Ioana, IORDACHE, C., TRANDAFIR, Laura. Evaluarea eficacităţii şi siguranţei atomoxetinei la copiii cu tulburare hiperactivitate/deficit de atenţie. In: Buletin de Perinatologie, 2009, nr. 3(43), pp. 202-205. ISSN 1810-5289. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Buletin de Perinatologie | ||||||
| Numărul 3(43) / 2009 / ISSN 1810-5289 | ||||||
|
||||||
| Pag. 202-205 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
Attention-defi cit/hyperactivity disorder (ADHD) is associated with impairments in educational, occupational, neuropsychological and family and social functioning
in children. Atomoxetine (ATMX) is the fi rst nonstimulant drug approved for the treatment of ADHD in 6 years of age children and adolescents. The aim of this
study is to evaluated ATMX efficacy and safety in 43 children with ADHD. The dose was gradually increased from 0,5 mg/kg/day to a maximum of 1,8 mg/kg/day based
on efficacy and tolerability assessed by the investigator. After 6 month 72,09% of children showed response of treatment with ATMX, with significant reductions in
ADHD Rating Scale-IV-Parent Version: Investigator- Administered and Scored and Clinical Global Impression ADHD Severity Scale scores. No serious adverse
event were observed. Treatment with ATMX is efficacy and safety in children with ADHD and represent a nonstimulant therapeutic alternative. |
||||||
| Cuvinte-cheie attention-defi cit/hyperactivity disorder, atomoxetine, child |
||||||
|
|
|
|
